India Globalization Capital, Inc.
(NYSE Amex Equities : IGC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
1.01%296.831.4%$601.48m
AMGNAmgen, Inc.
0.32%236.741.3%$495.31m
GILDGilead Sciences, Inc.
-2.75%65.771.0%$370.34m
REGNRegeneron Pharmaceuticals, Inc.
1.15%376.422.6%$305.23m
VRTXVertex Pharmaceuticals, Inc.
-0.71%218.981.9%$275.99m
ILMNIllumina, Inc.
0.85%324.723.5%$241.12m
CLVSClovis Oncology, Inc.
-4.24%12.8614.7%$219.13m
SRPTSarepta Therapeutics, Inc.
31.43%132.0514.6%$207.70m
ALXNAlexion Pharmaceuticals, Inc.
-1.82%110.422.0%$199.61m
ARWRArrowhead Pharmaceuticals, Inc.
-1.28%66.4611.4%$199.52m
AAgilent Technologies, Inc.
-1.30%83.711.6%$164.84m
EXASEXACT Sciences Corp.
2.08%87.2024.0%$164.17m
BLUEbluebird bio, Inc.
6.78%89.7514.2%$152.73m
GBTGlobal Blood Therapeutics, Inc.
-0.01%76.886.0%$140.08m
BOLDAudentes Therapeutics, Inc.
0.05%59.401.4%$136.27m

Company Profile

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through the Infrastructure Business and Plant & Cannabinoids Business segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Plant & Cannabinoids Business segment comprises the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.